Silence Therapeutics plc
SLN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $82 | $42 | $65 | $121 |
| Short-Term Investments | $20 | $72 | $72 | $26 |
| Receivables | $22 | $20 | $17 | $27 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $9 | $14 | $16 | $13 |
| Total Curr. Assets | $134 | $149 | $170 | $187 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $2 |
| Goodwill | $11 | $11 | $10 | $9 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $4 | $4 | $4 |
| Total NC Assets | $13 | $17 | $16 | $15 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $147 | $165 | $185 | $203 |
| Liabilities | – | – | – | – |
| Payables | $17 | $14 | $19 | $4 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $12 |
| Total Curr. Liab. | $17 | $15 | $19 | $17 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $55 | $56 | $53 | $52 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $225 | $0 |
| Total NC Liab. | $55 | $56 | $279 | $52 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $73 | $71 | $298 | $69 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $10 | $10 | -$10 | $10 |
| Retained Earnings | -$551 | -$530 | $503 | -$474 |
| AOCI | -$3 | -$1 | $8 | -$12 |
| Other Equity | $618 | $615 | -$613 | $610 |
| Total Equity | $74 | $94 | -$113 | $134 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $147 | $165 | $185 | $203 |
| Net Debt | -$82 | -$42 | -$65 | -$121 |